Home ›
Organizations ›
ADVENTIST GLENOAKS HOSPITAL
ADVENTIST GLENOAKS HOSPITAL
IL · EIN 363208390
44
Executives Disclosed
$126.9M
Annual Revenue
$72.6M
Total Assets
14.4:1
Internal Pay Ratio
ADVENTIST GLENOAKS HOSPITAL has 44 executives with disclosed compensation. The highest-paid executive, Randall Haffner, PHD (DIR/CHAIRMAN (END 2/21)), received peak total compensation of $3,829,282.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Randall Haffner, PHD | DIR/CHAIRMAN (END 2/21) | $3.8M | $3.8M | 2018–2021 | 51.1x |
| Kenneth Bacon | DIR/CHAIRMAN | $1.9M | $1.9M | 2021–2022 | 25.5x |
| Brent Snyder | DIRECTOR | $1.8M | $1.5M | 2021–2022 | 24.4x |
| Brent G Snyder | DIRECTOR | $1.7M | $1.5M | 2018–2019 | 22.2x |
| Bruce Christian | PRES/CEO BOLINGBROOK/GLENOAKS (END 10/22) | $1.6M | $1.6M | 2018–2022 | 21.7x |
| Thor Thordarson | DIR/PRESIDENT/SEC | $1.4M | $1.4M | 2018–2022 | 19.3x |
| Herbert Buchanan | DIRECTOR | $822K | $829K | 2019–2022 | 11x |
| Richard Carroll, MD | VP/CMO BOLINGBROOK/GO (END 6/22) | $728K | $528K | 2018–2022 | 9.7x |
| Richard Roehr | FORMER COO | $568K | $568K | 2018–2021 | 7.6x |
| Eric Yang, MD | DIRECTOR (END 12/19) | $491K | $453K | 2018–2019 | 6.5x |
| Ramadevi Davarapalli, MD | DIRECTOR (BEG 1/22) | $490K | $490K | 2022–2022 | 6.5x |
| David Crane | FORMER REGIONAL CEO | $453K | $453K | 2018–2018 | 6x |
| Vladimir Radivojevic | COO/CEO | $429K | $429K | 2018–2022 | 5.7x |
| Colleen Pawlik, RN | INTERIM CNO BOLING/GLENOAKS | $344K | $344K | 2021–2022 | 4.6x |
| Jared Brown | SR. DIR. FINANCE-BOLING/GLENOAKS | $275K | $265K | 2019–2022 | 3.7x |
| De Ramos Do David | DIRECTOR (END 12/22) | $271K | $271K | 2019–2022 | 3.6x |
| Carol Pfeifer | CNO | $255K | $255K | 2019–2019 | 3.4x |
| Jolene Albaugh | RN DIR-SURGICAL SVCS | $202K | $188K | 2019–2022 | 2.7x |
| Chase Aalborg | VP/CFO GLENOAKS/BOLINGBROOK END 9/18 | $199K | $199K | 2018–2018 | 2.7x |
| Miguel Dominguez | RN DIR-NURSING | $194K | $192K | 2019–2021 | 2.6x |
| Sinol Thorakkal | RN CHARGE | $192K | $207K | 2021–2022 | 2.6x |
| Bissy Punnoose | RN BEHAVORIAL HEALTH | $184K | $184K | 2018–2019 | 2.5x |
| Lisa Grigsby | DIR-EDUCATIONAL SVCS | $182K | $182K | 2018–2021 | 2.4x |
| Leticia Tiangson | RN EMERGENCY DEPT | $173K | $173K | 2019–2019 | 2.3x |
| Christin Kruse | AVP-BUSINESS OPERATIONS | $169K | $169K | 2018–2018 | 2.3x |
| Leizl Mayol | RN SPV-HOUSE | $165K | $205K | 2022–2022 | 2.2x |
| Lawrence Giambelluca | MGR-PHARMACY | $164K | $164K | 2018–2021 | 2.2x |
| Fatima Calanza | RN CHARGE | $161K | $219K | 2022–2022 | 2.1x |
| Lisa Knutson | RN DIR-NURSING | $157K | $196K | 2022–2022 | 2.1x |
| Dena Roehr | DIR-NURSING II | $154K | $154K | 2018–2018 | 2x |
| Sherril Vincent | INTERIM VP/CFO BOLINGBROOK(END 1/19) | $64K | $0 | 2018–2019 | 0.8x |
| Scott Guth, MD | DIRECTOR | $62K | $0 | 2018–2021 | 0.8x |
| Susan Murrey, MD | DIRECTOR | $49K | $0 | 2022–2022 | 0.7x |
| Deborah Schimerowski | CFO | $38K | $0 | 2018–2019 | 0.5x |
| Greg Sharon, MD | DIRECTOR (END 12/18) | $33K | $0 | 2018–2018 | 0.4x |
| Maninder Kohli, MD | DIRECTOR (BEG 1/22) | $31K | $0 | 2022–2022 | 0.4x |
| Carlos Martinez, MD | DIRECTOR | $29K | $0 | 2018–2021 | 0.4x |
| Christine Budzinsky | CNO | $19K | $19K | 2018–2018 | 0.2x |
| Henry Zeisel | CFO | $18K | $0 | 2018–2019 | 0.2x |
| Ronald Aguilera | DIRECTOR (END 3/22) | $6K | $0 | 2018–2022 | 0.1x |
| Kenneth Denslow | DIRECTOR/VICE CHAIR | $6K | $0 | 2021–2022 | 0.1x |
| Elden Ramirez | DIRECTOR (BEG 1/22) | $5K | $0 | 2022–2022 | 0.1x |
| Glynn Scott | DIRECTOR | $5K | $0 | 2018–2022 | 0.1x |
| Mdiv Maurice Valentine, II | DIRECTOR/VICE CHAIR (END 4/21) | $4K | $0 | 2018–2021 | 0.1x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2018 | 25 | $535K | $3.3M | $9.6M |
| 2019 | 25 | $589K | $3.0M | $10.0M |
| 2021 | 23 | $762K | $3.8M | $13.0M |
| 2022 | 22 | $667K | $1.9M | $10.7M |